| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |